OncoMed Pharmaceuticals Initiates Phase 1b/2 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 in Small Cell Lung Cancer and Amends Phase1b/2 Pancreatic Cancer Trial Anti-Notch2/3 Phase 1b/2 ALPINE Trial in Pancreatic Cancer Amended to Include Gemcitabine and Abraxanea Chemotherapy REDWOOD CITY, Calif.-- --OncoMed Pharmaceuticals, Inc., ... (more)
http://www.businesswire.com/news/topix/20130514006912/en
http://www.businesswire.com/news/topix/20130514006912/en
No comments:
Post a Comment